Follistatin-like protein 1: A serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis

Arthritis Research and Therapy

Volumn 13, Issue 6, 2011, Pages

  Wang, Yuji ^a,b   Li, Dawei ^b   Xu, Nanwei ^a   Tao, Weijian ^c   Zhu, Ruixia ^a   Sun, Rongbin ^a   Fan, Weiwei ^b   Zhang, Ping ^a   Dong, Tianhua ^d   Yu, Long ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Suzhou Xiangcheng People's Hospital   (China)

^d THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Biochemical marker; Fstl1; Kl grade; Osteoarthritis; Womac score

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FOLLISTATIN LIKE PROTEIN 1; FOLLISTATIN RELATED PROTEIN; GLYCOPROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ARTICULAR CARTILAGE; CAPILLARY ENDOTHELIUM; CARTILAGE CELL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOPLASM; DISEASE DURATION; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; JOINT DESTRUCTION; JOINT STIFFNESS; LINEAR REGRESSION ANALYSIS; MALE; OSTEOARTHRITIS; PATIENT MONITORING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SYNOVIAL FLUID LEVEL; SYNOVIUM; WESTERN BLOTTING; AGED; BLOOD; GENETICS; KNEE; KNEE OSTEOARTHRITIS; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; SYNOVIAL FLUID;

ADULT; AGED; BIOLOGICAL MARKERS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLISTATIN-RELATED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KNEE JOINT; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOARTHRITIS, KNEE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 82055164010     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3522     Document Type: Article

References (25)

1. Dieppe PA, Lohmander LS. Pathogenesis and management of pain in osteoarthritis. Lancet 2005, 365:965-973. 10.1016/S0140-6736(05)71086-2, 15766999.
2. Felson DT. Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther 2009, 11:203. 10.1186/ar2531, 2688214, 19232065.
3. Rousseau JC, Delmas PD. Biological markers in osteoarthritis. Nat Clin Pract Rheumatol 2007, 3:346-356. 10.1038/ncprheum0508, 17538566.
4. van Spil WE, DeGroot J, Lems WF, Oostveen JC, Lafeber FP. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthritis Cartilage 2010, 18:605-612. 10.1016/j.joca.2010.01.012, 20175979.
5. Shibanuma M, Mashimo J, Mita A, Kuroki T, Nose K. Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide. Eur J Biochem 1993, 217:13-19. 10.1111/j.1432-1033.1993.tb18212.x, 7901004.
6. Oshima Y, Ouchi N, Sato K, Izumiya Y, Pimentel DR, Walsh K. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation 2008, 117:3099-3108. 10.1161/CIRCULATIONAHA.108.767673, 2679251, 18519848.
7. Ouchi N, Oshima Y, Ohashi K, Higuchi A, Ikegami C, Izumiya Y, Walsh K. Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a Nitric-oxide synthase-dependent mechanism. J Biol Chem 2008, 283:32802-32811. 10.1074/jbc.M803440200, 2583310, 18718903.
8. Clutter SD, Wilson DC, Marinov AD, Hirsch R. Follistatin-like protein 1 promotes arthritis by up-regulating IFN-gamma. J Immunol 2009, 182:234-239. 3150499, 19109154.
9. Li D, Wang Y, Xu N, Wei Q, Wu M, Li X, Zheng P, Sun S, Jin Y, Zhang G, Liao R, Zhang P. Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis. Arthritis Res Ther 2011, 13:R17. 10.1186/ar3241, 3241361, 21303509.
10. Tanaka M, Ozaki S, Osakada F, Mori K, Okubo M, Nakao K. Cloning of follistatin-related protein as a novel autoantigen in systemic rheumatic diseases. Int Immunol 1998, 10:1305-1314. 10.1093/intimm/10.9.1305, 9786430.
11. Tanaka M, Ozaki S, Kawabata D, Kishimura M, Osakada F, Okubo M, Murakami M, Nakao K, Mimori T. Potential preventive effects of follistatin-related protein/TSC-36 on joint destruction and antagonistic modulation of its autoantibodies in rheumatoid arthritis. Int Immunol 2003, 15:71-77. 10.1093/intimm/dxg005, 12502727.
12. Kawabata D, Tanaka M, Fujii T, Umehara H, Fujita Y, Yoshifuji H, Mimori T, Ozaki S. Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis. Arthritis Rheum 2004, 50:660-668. 10.1002/art.20023, 14872511.
13. Le Luduec JB, Condamine T, Louvet C, Thebault P, Heslan JM, Heslan M, Chiffoleau E, Cuturi MC. An immunomodulatory role for follistatin-like 1 in heart allograft transplantation. Am J Transplant 2008, 8:2297-2306. 10.1111/j.1600-6143.2008.02398.x, 18925901.
14. Adams DC, Karolak MJ, Larman BW, Liaw L, Nolin JD, Oxburgh L. Follistatin-like 1 regulates renal IL-1β expression in cisplatin nephrotoxicity. Am J Physiol Renal Physiol 2010, 299:F1320-1327. 10.1152/ajprenal.00325.2010, 3006315, 20861081.
15. Miyamae T, Marinov AD, Sowders D, Wilson DC, Devlin J, Boudreau R, Robbins P, Hirsch R. Follistatin-like protein-1 is a novel proinflammatory molecule. J Immunol 2006, 177:4758-4762.
16. Widera C, Horn-Wichmann R, Kempf T, Bethmann K, Fiedler B, Sharma S, Lichtinghagen R, Leitolf H, Ivandic B, Katus HA, Giannitsis E, Wollert KC. Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay. Clin Chem 2009, 55:1794-1800. 10.1373/clinchem.2009.129411, 19574466.
17. Wilson DC, Marinov AD, Blair HC, Bushnell DS, Thompson SD, Chaly Y, Hirsch R. Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 2010, 62:2510-2516. 10.1002/art.27485, 2921021, 20506332.
18. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, Howell D, Kaplan D, Koopman W, Longley S, Mankin H, McShane DJ, Medsger T, Meenan R, Mikkelsen W, Moskowitz R, Murphy W, Rothschild B, Segal M, Sokoloff L, Wolfe F. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29:1039-1049. 10.1002/art.1780290816, 3741515.
19. Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K, Brown C, Cooke TD, Daniel W, Feldman D, Greenwald R, Hochberg M, Howell D, Ike R, Kapila P, Kaplan D, Koopman W, Marino C, McDonald E, McShane DJ, Medsger T, Michel B, Murphy WA, Osial T, Ramsey-Goldman R, Rothschild B, Wolfe F. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991, 34:505-514. 10.1002/art.1780340502, 2025304.
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
21. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988, 15:1833-1840.
22. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957, 16:494-502. 10.1136/ard.16.4.494, 1006995, 13498604.
23. Ashraf S, Walsh DA. Angiogenesis in osteoarthritis. Curr Opin Rheumatol 2008, 20:573-580. 10.1097/BOR.0b013e3283103d12, 18698180.
24. Szekanecz Z, Koch AE. Vascular involvement in rheumatic diseases: 'vascular rheumatology'. Arthritis Res Ther 2008, 10:224. 10.1186/ar2515, 2592799, 18947376.
25. Bauer DC, Hunter DJ, Abramson SB, Attur M, Corr M, Felson D, Heinegård D, Jordan JM, Kepler TB, Lane NE, Saxne T, Tyree B, Kraus VB, . Osteoarthritis Biomarkers Network Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage 2006, 14:723-727. 10.1016/j.joca.2006.04.001, 16733093, Osteoarthritis Biomarkers Network.